Most Clicked SNMMI SmartBrief Stories

1. Thyroid cancer recurrence spotted with PET/CT

SNMMI SmartBrief | Aug 18, 2014

PET/CT pinpoints thyroid disease recurrence not spotted with radioiodine imaging, according to findings to be presented at the Royal College of Radiologists Annual Scientific Meeting in London. Researchers found that PET/CT detected lesions in 12 of 23 thyroid cancer patients who had a negative thyroid scan but high serum thyroglobulin levels. Diagnostic Imaging (08/15)

2. NorthStar to supply GE Healthcare with radioisotopes

SNMMI SmartBrief | Aug 15, 2014

NorthStar Medical Radioisotopes has agreed to provide molybdenum-99 to GE Healthcare, provided its nonuranium technology and RadioGenix system are approved by the FDA and made commercially available. (free registration) (08/14)

3. New domestic HQ for GE Healthcare Life Sciences headed to Mass.

SNMMI SmartBrief | Aug 21, 2014

GE Healthcare Life Sciences has announced it will open a new 160,000-square-foot U.S. headquarters in Marlborough, Mass. The facility will house more than 500 employees and will establish at least 220 new jobs, according to officials. The headquarters, expected to open next year, will have laboratories, office space and more. Genetic Engineering & Biotechnology News (08/20)

4. Study: Metformin might help explain diabetes-cognition link

SNMMI SmartBrief | Aug 15, 2014

A study published in Diabetes Care showed type 2 diabetes patients on metformin treatment had a 123% increased risk of cognitive decline compared with those not using the drug. Researchers also found diabetes patients who took calcium supplements were more likely than those who didn't to have better cognitive outcomes. (08/13)

5. Who and what was influential in JNM

SNMMI SmartBrief | Aug 19, 2014

Have you read the most influential JNM articles from the past two years? Did you or your colleague author one of them? Review the 50 hottest papers and researchers based on citations accrued. Blank (08/19)

6. Physical activity linked to brain connectivity in children

SNMMI SmartBrief | Aug 20, 2014

Brain scans of 24 9- and 10-year-olds showed improved white matter structure among physically active children, possibly linked to differences in blood flow. The study was published in the journal Frontiers in Human Neuroscience. HealthDay News (08/19)

7. 2015-16 SNMMI Post-Doctoral Molecular Imaging Research Scholar Program

SNMMI SmartBrief | Aug 15, 2014

The postdoctoral program will support a two-year research endeavor that promotes integration of molecular imaging into the career of the trainee. This $65,000 grant provides $32,500 annually for two years and is made possible through a grant from the Education and Research Foundation for Nuclear Medicine and Molecular Imaging. Application deadline is Oct. 31. Learn more and submit your application. Blank (07/30)

8. Study finds brain connectivity differences in teens who engage in risky behavior

SNMMI SmartBrief | Aug 20, 2014

A study in the journal Psychiatry Research: Neuroimaging showed that risk-taking behavior in teens may be associated with hyperconnectivity in the emotional-regulation network of the brain. Functional MRI scans of 18 risk-takers showed hyperconnectivity between the amygdala and parts of the prefrontal cortex, compared with 18 non-risk-takers, as well as between the prefrontal cortex and nucleus accumbens, which is associated with reward and addiction. Medical News Today (08/19)

9. Research focuses on possible epigenetic aspect of Alzheimer's

SNMMI SmartBrief | Aug 19, 2014

DNA methylation appears to play a role in Alzheimer's disease, according to a study in the journal Nature Neuroscience, although it's not clear whether the change is a cause or effect of the disorder. Researchers who looked at postmortem samples from 708 people found the most prominent differences in methylation between the AD and control tissue samples were in the ANK1 gene, particularly in the entorhinal cortex, a key site of AD manifestation. The gene has not previously been associated with AD, "but genetic studies have linked it to type 2 diabetes, which, in turn, has links to dementia, so there could be some common pathway linking the two diseases," said researcher Jonathan Mill. New Scientist (08/17)

10. New agents inactivate RNA from mutated gene in ALS and FTD

SNMMI SmartBrief | Aug 15, 2014

Two of the three novel small-molecule agents designed by researchers with the Scripps Research Institute and the Mayo Clinic reduced the burden of c9RAN, a toxic protein associated with amyotrophic lateral sclerosis and frontotemporal dementia, according to a study in the journal Neuron. The toxic proteins are encoded in a mutated form of the C90RF72 gene, present in both disorders. The molecules work by inhibiting the encoded RNA's ability to interact with other vital proteins. Medical News Today (08/14)

Sign up for SNMMI SmartBrief

Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession. Learn more